AU1799097A - Presentation of antigen, introduced into the cells by stimulation of macropinocytosis - Google Patents

Presentation of antigen, introduced into the cells by stimulation of macropinocytosis

Info

Publication number
AU1799097A
AU1799097A AU17990/97A AU1799097A AU1799097A AU 1799097 A AU1799097 A AU 1799097A AU 17990/97 A AU17990/97 A AU 17990/97A AU 1799097 A AU1799097 A AU 1799097A AU 1799097 A AU1799097 A AU 1799097A
Authority
AU
Australia
Prior art keywords
macropinocytosis
stimulation
antigen
presentation
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU17990/97A
Inventor
Colin Watts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Dundee
Original Assignee
University of Dundee
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9526269.7A external-priority patent/GB9526269D0/en
Application filed by University of Dundee filed Critical University of Dundee
Publication of AU1799097A publication Critical patent/AU1799097A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55516—Proteins; Peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU17990/97A 1995-12-21 1996-12-23 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis Abandoned AU1799097A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GBGB9526269.7A GB9526269D0 (en) 1995-12-21 1995-12-21 Method
GB9526269 1995-12-21
US64889496A 1996-05-16 1996-05-16
US648894 1996-05-16
PCT/GB1996/003214 WO1997023607A2 (en) 1995-12-21 1996-12-23 Presentation of antigen, introduced into cells by stimulation of macropinocytosis

Publications (1)

Publication Number Publication Date
AU1799097A true AU1799097A (en) 1997-07-17

Family

ID=26308366

Family Applications (1)

Application Number Title Priority Date Filing Date
AU17990/97A Abandoned AU1799097A (en) 1995-12-21 1996-12-23 Presentation of antigen, introduced into the cells by stimulation of macropinocytosis

Country Status (3)

Country Link
EP (1) EP0910632A2 (en)
AU (1) AU1799097A (en)
WO (1) WO1997023607A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005021712A2 (en) * 2003-06-25 2005-03-10 Georgia Tech Research Corporation Modified molecular beacons
CN110251682B (en) * 2011-11-24 2022-12-06 苏州宝时得电动工具有限公司 Polypeptide sequence design and application thereof in polypeptide-mediated siRNA delivery

Also Published As

Publication number Publication date
WO1997023607A2 (en) 1997-07-03
WO1997023607A3 (en) 1997-09-18
EP0910632A2 (en) 1999-04-28

Similar Documents

Publication Publication Date Title
AU5316096A (en) Gene therapy by secretory gland expression
AU7478394A (en) Methods for (ex vivo) therapy using peptide-loaded antigen presenting cells for the activation of ctl
AU6095696A (en) Immunogenic peptides of prostate specific antigen
AU5268696A (en) Novel compounds and methods for therapy
AU5393796A (en) Bioreactor
AU7612196A (en) Functional human hematopoietic cells
AU7608596A (en) Improved high chair system
AU5930396A (en) Allogeneic cell therapy for cancer following allogeneic stem cell transplantation
AU7739596A (en) Improved hyperbaric chamber
AU4329396A (en) Use of 3,4-diphenylchromans
AU5507098A (en) Enhancement of dna immunization through the use of cytokines
AU5168496A (en) Butyryl-tyrosinyl spermine, analogs thereof and methods of preparing and using same
AU5315096A (en) 19-oxygenated steroids as therapeutic agents
AU5058196A (en) Process for the preparation of 1,1-difluoroethane
AU6130196A (en) Cell treatment
AU4729396A (en) Process for the preparation of 1,2-benzisothiazolin-3-ones
AU6496094A (en) Tumor-associated antigens recognized by t cells and the uses of these antigens
AU7301596A (en) Chair
AU5486396A (en) Process for the preparation of spiroindolines
AU7096496A (en) Process for the preparation of 4-methylenepiperidines
AU1799097A (en) Presentation of antigen, introduced into the cells by stimulation of macropinocytosis
AU2818695A (en) Natural killer cell enhancing factor c
AU6746296A (en) Cell culture products
AU7097696A (en) Novel human cc chemokine
AU8842798A (en) Process for the preparation of ivermectin